TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
PLRX

Pliant Therapeutics Inc

Healthcare · Biotechnology

1.10$ -1.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PLRX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.00 1.60 1.18 0.21 0.23 0.03 0.00 0.00
– 0.04 – – 0.09 0.09 0.03 0.04 0.03
– -0.04 1.60 1.18 0.21 0.23 0.03 -0.04 -0.03
18.08 1.48 1.33 1.86 2.16 2.31 2.18 2.80 1.78
4.76 0.39 0.31 0.49 0.77 0.95 0.99 0.98 0.77
22.84 1.87 1.64 2.35 0.77 3.26 3.16 3.77 2.42
-22.84 -1.87 -0.03 -1.17 -0.56 -3.03 -3.14 -3.77 -2.45
0.00 0.00 0.01 0.01 0.01 0.02 0.02 0.05 0.04
-22.82 -1.83 -0.02 -1.17 -0.55 -2.94 -2.75 -3.47 -2.43
2.85 0.04 -0.02 -0.05 -0.05 -0.04 0.03 – –
-25.67 -1.83 -0.02 -1.12 -0.50 -2.94 -2.75 -3.47 -2.43
-22.47 -1.83 0.00 -1.13 -0.51 -2.83 -2.69 -3.39 -2.36

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?